Dynamic serum tumor-marker and immune-inflammatory biomarker changes for risk stratification of immune checkpoint inhibitor-associated myasthenia gravis in non-small cell lung cancer.

Cui P, Lin X, Luo W, Zhang S, Zhang S, Xu S, Lai J, Xiong Y, Chen D, Huang B, Xu Z

Open source

DOI
10.3389/fimmu.2026.1929526
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1929526,
  title = {Dynamic serum tumor-marker and immune-inflammatory biomarker changes for risk stratification of immune checkpoint inhibitor-associated myasthenia gravis in non-small cell lung cancer.},
  author = {Cui P and Lin X and Luo W and Zhang S and Zhang S and Xu S and Lai J and Xiong Y and Chen D and Huang B and Xu Z},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1929526},
  url = {https://doi.org/10.3389/fimmu.2026.1929526}
}

RIS

TY  - JOUR
TI  - Dynamic serum tumor-marker and immune-inflammatory biomarker changes for risk stratification of immune checkpoint inhibitor-associated myasthenia gravis in non-small cell lung cancer.
AU  - Cui P
AU  - Lin X
AU  - Luo W
AU  - Zhang S
AU  - Zhang S
AU  - Xu S
AU  - Lai J
AU  - Xiong Y
AU  - Chen D
AU  - Huang B
AU  - Xu Z
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1929526
UR  - https://doi.org/10.3389/fimmu.2026.1929526
ER  - 

APA

P, C., X, L., W, L., S, Z., S, Z., S, X., J, L., Y, X., D, C., B, H., & Z, X. (2026). Dynamic serum tumor-marker and immune-inflammatory biomarker changes for risk stratification of immune checkpoint inhibitor-associated myasthenia gravis in non-small cell lung cancer.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1929526

Source records